- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Jacob Ballon: Looking Beyond Schizophrenia Symptoms to Treat the Whole Person
Providers should treat patients with schizophrenia by thinking about them as people and understanding the full context of their lives, according to Jacob Ballon, MD, MPH, clinical associate professor, psychiatry and behavioral sciences, Stanford University.
Providers should treat patients with schizophrenia by thinking about them as people and understanding the full context of their lives, according to Jacob Ballon, MD, MPH, clinical associate professor, psychiatry and behavioral sciences, Stanford University.
Transcript
How can understanding the brain­—body connections help psychiatrists better understand people with psychosis?
Well, we need to be thinking about people as people, and that means thinking about not just their brains but their bodies and the full context of their life. Nobody wants to be narrowly defined by their symptoms, and so that means thinking about how are we managing both their medications but also their general role in their life and what are they doing, how are they involved with their peers, and how is their overall health? We know that people with schizophrenia have a shortened lifespan, and we need to be thinking about how to provide medication and other treatments that are going to maximize their health, and not just thinking about managing their psychiatric symptoms.
What is the potential role of exercise in the treatment of psychiatric disorders?
Exercise is important. Again, if we want to think about physical health and overall health, exercise is always going to play a role. We know that people with schizophrenia, again, have a shortened lifespan, often due to cardiovascular complications, and so exercise is helpful for that. But we also know that exercise can help to improve people’s cognition, and we did a study that found that increased levels of BDNF, or brain-derived neurotrophic factor, which is a neurofactor that helps with sprouting neurons and helping enhance cognition, was increased with 3 times a week aerobic exercise. And so as a result, we know that it’s important if we’re going to think about schizophrenia as more than just an illness that is about delusions and hallucinations, that we’re treating all of the symptoms and we’re treating the whole person.
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
The IRA’s Unintended Consequences for Drug Pricing and Coverage
April 2nd 2025The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling pharmaceutical innovation, experts warned at the Academy of Managed Care Pharmacy 2025 annual meeting.
Read More
